VEGFA and age-related macular degeneration: In 2004, Macugen, an anti-VEGF (Vascular Endothelial Growth Factor) inhibitor, became the first aptamer approved by the Food and Drug Administration (FDA) for Age-Related Macular Degeneration (AMD) [19].